Not 100% accurate actually there is definitely a benefit in specificity and efficacy if the vaccine is prepared form attenuated virus form such a variant and strain as you suggest. yet the science of vaccination is such that preparation is always proactive NOT reactive. Deploying a vaccine in the middle of a pandemic would be largely a wasted effort.
Far better to prepare a vaccine based on the current H5N1 variant and gain approx as much as 60-70% efficacy from the cross immune benefit.
Hi, Kelly! Dang, am I glad to see you!
Thanks for your remarks, I really appreciate the time you are taking to post them.
Please check my post 54 and let me know what you think...as far as I know, there is no reason an influenza virus must "trade" pathogenicity for transmissibility, yet that story is going around not only here but elsewhere on the internet.
People are *assuming* that by the time H5N1 has gained the h2h2h2h2h ability, it will not have the same death rate as it seems to now--over 50%. I don't see any reason to *assume* that.
I am reminded of the Artic eskimo village where 70% of the population died of H1N1 in 1918...